娄亮将于2020年6月在郑州大学获得学士学位，保研进入中山大学药学院(深圳)高理钱老师课题组开始研究生期间的学习，为中山大学2020级硕士、博士(2021)连读研究生。

E-mail: louliang@mail2.sysu.edu.cn

Publications (After joining SYSU) (# Equal contribution, * Corresponding author）

1. Q. Xiao*, X. Dong, F. Yang, S. Zhou, M. Xiang, L. Lou, S.Q. Yao*，L. Gao*, “Engineered Cell-penetrating Peptides for Mitochondrion-Targeted Drug Delivery in Cancer Therapy”, Chem. Eur. J.  (2021), 27(59), 14721-14729. 

2.  P. Chen#, L. Lou #,  B. Sharma, M. Li, C. Xie, F. Yang , Y. Wu*, Q. Xiao *, L. Gao*, “Recent advances on PKM2 modulators including inhibitors and activators in biomedical applications",Current Medicinal Chemistry (2023),  in press, DOI: 10.2174/0929867331666230714144851. 

3.  L. Lou#, S. Zhou#, S. Tan#, M. Xiang, W. Wang, C. Yuan*, L. Gao* and Q. Xiao*, “Amplifying the Efficacy of ALA-based Prodrugs for Photodynamic Therapy Using Nanotechnology”, Frontiers in Pharmacology (2023), 14:1137707. 

4. J. Sun#, L. Lou#, C-J Zhu#, P. Chen, G. Tang, M. Gu, S. Xia, X. Dong,* Z.-M. Zhang,* L. Gao,* S.Q. Yao,* Q. Xiao*,“Chemical Evolution to Improve Bcr-Abl Kinase Inhibitors via Covalent and Pro-/Dual-drug Targeting Strategies”, J. Adv. Res. (2024), in press.